| Unique ID issued by UMIN | UMIN000057408 |
|---|---|
| Receipt number | R000065595 |
| Scientific Title | A Multicenter Randomized Open-Label Study evaluating AI-powered applications for dietary intake in gastric cancer patients who receive curative treatment |
| Date of disclosure of the study information | 2025/03/26 |
| Last modified on | 2025/03/26 15:38:05 |
A Multicenter Randomized Open-Label Study evaluating AI-powered applications for dietary intake in gastric cancer patients who receive curative treatment
A Multicenter Randomized Open-Label Study evaluating AI-powered applications for dietary intake in gastric cancer patients who receive curative treatment
A Multicenter Randomized Open-Label Study evaluating AI-powered applications for dietary intake in gastric cancer patients who receive curative treatment
A Multicenter Randomized Open-Label Study evaluating AI-powered applications for dietary intake in gastric cancer patients who receive curative treatment
| Japan |
Gastric Cancer
| Surgery in general | Gastrointestinal surgery |
Malignancy
NO
This randomized controlled trial evaluates AI-powered applications for dietary intake and confirmed usefulness and improve the dietary intake and QOL after gastrectomy.
Safety
Exploratory
The primary endpoint was changes QOL score using Short Form-36 Health Survey (SF-36) during 4 weeks after registration.
The secondary endpoints were changes of oral dietary intake, body composition changes, and laboratory data during 4 weeks after registration.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
| Medicine |
AI-powered applications support
no AI-powered applications support
| 18 | years-old | <= |
| 90 | years-old | > |
Male and Female
1. age 18 years and over
2. patients who have undergone radical resection for gastric cancer
3. patients who can cook at home and take food orally after being discharged from hospital.
4. the patient must be able to access the internet environment and own a device that can use this website.
5. the patient's written consent to participate in the study has been obtained.
1.Patient who do not have access to the Internet environment or do not have a device capable of using the Site.
2.Patients who are unable to use the Site due to cognitive or physical impairment or disability.
3.Patients who do not have access to a cooking environment at home or who are unable to take food orally.
4.Patients who are already using ReTabell at the time of registration or have withdrawn their consent to the Terms of Use and Agreement.
5.Patients deemed inappropriate for inclusion in the study by the principal investigator or co-principal investigator.
76
| 1st name | Aoyama |
| Middle name | |
| Last name | Toru |
Yokohama City University
Department of Surgery
2360004
3-9 Fukuura Kanazawa0ku Yokohama
0457872800
t-aoyama@lilac.plala.or.jp
| 1st name | Hashimoto |
| Middle name | |
| Last name | Itaru |
Yokohama City University
Department of Surgery
236-0004
3-9 Fukuura Kanazawa0ku Yokohama
0457972800
itarum1n1@hotmail.com
Yokohama City University
Ajinomoto Co., Inc.
Daiichi Sankyo Company, Limited
Profit organization
Yokohama City University
3-9 Fukuura kanazawa-ku Yokohama
0457872800
rinri@yokohama-cu.ac.jp
NO
| 2025 | Year | 03 | Month | 26 | Day |
Unpublished
Preinitiation
| 2025 | Year | 03 | Month | 06 | Day |
| 2025 | Year | 06 | Month | 01 | Day |
| 2026 | Year | 06 | Month | 30 | Day |
| 2025 | Year | 03 | Month | 26 | Day |
| 2025 | Year | 03 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065595